Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study.

World J Gastroenterol · 2026 · PMC12898754 · PMID 41695287

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Endoscopic assessment in FILGUITO showed a trend toward improvement, with mean Mayo endoscopic subscore decreasing from 2.17 at baseline to 1.71 at 12 months, though this did not reach statistical significance.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

The mean Mayo endoscopic score decreased from 2.17 at baseline to 2.0 at 6 months and 1.71 at 12 months; these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.